Latest Headlines

  1. AveXis To Build New Gene Therapy Drug Manufacturing Facility In North Carolina

    AveXis, an Illinois-based clinical-stage company developing gene therapies for neurological genetic diseases, is investing $55M in a new Durham manufacturing facility that will create 200 jobs.


  2. Bosch Packaging Technology Sponsors 2018 PDA Visual Inspection Interest Group Workshop

    Robert Bosch Packaging Technology Inc., a leader in supplying pharmaceutical inspection equipment, was honored to recently sponsor the 2018 PDA Visual Inspection Interest Group Workshop this year in Bethesda, Maryland.  Bosch was proud to showcase its latest manual inspection units and display the various innovations and lighting options currently offered by the product line.  Manual inspection will always be a cornerstone in the realm of visual inspection.  Whether it be setting the benchmark for acceptable product or establishing the baseline for validating semi-automatic and automatic visual inspection machinery; manual inspection is critical within the pharmaceutical industry.

  3. Kite Announces New Worldwide Facilities To Support Cell Therapy Drug Pipeline

    Kite, a Gilead Company, recently announced it has leased a new facility in the Netherlands to engineer cell therapies in Europe.


  4. Bio-Rad Introduces Anti-Vedolizumab Antibodies

    Bio-Rad Laboratories, Inc. a global leader of life science research and clinical diagnostic products, recently announced the release of a range of anti-vedolizumab antibodies.Bio-Rad Laboratories, Inc. a global leader of life science research and clinical diagnostic products, recently announced the release of a range of anti-vedolizumab antibodies.

  5. Parker Bioscience Launches New System To Support Process And Product Protection

    Parker Bioscience has launched a new system which combines the fully automated bulk filtration and dispensing of biopharmaceutical products with a unique and validated shipping solution that ensures product integrity across the supply chain.

  6. Catalent Biologics And Valerius Biopharma To Collaborate On Manufacture Of Specialty Biosimilars

    Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, and Valerius Biopharma AG, a Swiss biopharmaceutical company dedicated to providing interchangeable treatment options for high-priced orphan and non-orphan biologics, recently announced that they are to collaborate on the development and manufacture of Valerius’ biosimilar products.

  7. Karius Announces Launch Of Quantitative, Broad-Based Infectious Disease Diagnostic Test Using Microbial Cell-Free DNA

    Karius, the leading U.S. infectious disease genomics company, announced recently that the new version of its proprietary Karius Test can now quantify the abundance of pathogens detected.

  8. Novasep To Invest In New Commercial Aseptic Fill / Finish Manufacturing Facility

    Novasep, a leading supplier of services and technologies for the life sciences industry, announces a €10M investment in a commercial fill & finish facility for viral vectors, mAbs and other low-volume biologics.

  9. G-CON Manufacturing Chosen For New POD® Based 503B Facility

    G-CON Manufacturing, producer of prefabricated, flexible cleanroom solutions, announced today that is has been selected to design and build a multi-POD 503B manufacturing space.

  10. Thermo Fisher Announces Expansion Of St. Louis Biologics Site

    Thermo Fisher is investing $50 million in its St. Louis, Missouri site, which is one of the company’s Centers of Excellence (COE) for Biological Commercial Manufacturing. The investment is part of a deliberate strategy to continue expansion of the company’s global network of biologic drug substance capabilities for clinical and commercial supply.